Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premature Birth | 5 | 2016 | 75 | 1.760 |
Why?
|
| Infant Mortality | 3 | 2016 | 26 | 1.030 |
Why?
|
| Cerebral Palsy | 3 | 2016 | 82 | 0.970 |
Why?
|
| Pregnancy | 10 | 2016 | 1069 | 0.940 |
Why?
|
| Pregnancy Outcome | 3 | 2014 | 96 | 0.840 |
Why?
|
| Magnesium Sulfate | 3 | 2016 | 14 | 0.590 |
Why?
|
| Neuroprotective Agents | 2 | 2016 | 34 | 0.550 |
Why?
|
| Cesarean Section | 2 | 2016 | 122 | 0.500 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 30 | 0.470 |
Why?
|
| Pregnancy Complications | 2 | 2016 | 115 | 0.470 |
Why?
|
| Stillbirth | 2 | 2013 | 13 | 0.470 |
Why?
|
| Genomics | 1 | 2016 | 94 | 0.450 |
Why?
|
| Fetal Distress | 1 | 2014 | 3 | 0.430 |
Why?
|
| Uterine Rupture | 1 | 2014 | 18 | 0.430 |
Why?
|
| Trial of Labor | 1 | 2014 | 19 | 0.420 |
Why?
|
| Labor Stage, Second | 1 | 2013 | 2 | 0.420 |
Why?
|
| Labor Stage, First | 1 | 2013 | 9 | 0.410 |
Why?
|
| Fetofetal Transfusion | 1 | 2012 | 2 | 0.380 |
Why?
|
| Uterine Hemorrhage | 1 | 2012 | 9 | 0.380 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2012 | 13 | 0.380 |
Why?
|
| Twins, Dizygotic | 1 | 2012 | 6 | 0.380 |
Why?
|
| Twins, Monozygotic | 1 | 2012 | 13 | 0.380 |
Why?
|
| Logistic Models | 4 | 2016 | 808 | 0.370 |
Why?
|
| Epilepsy | 1 | 2013 | 86 | 0.350 |
Why?
|
| Retrospective Studies | 6 | 2016 | 3812 | 0.340 |
Why?
|
| Infant, Newborn | 4 | 2016 | 730 | 0.320 |
Why?
|
| Infant | 4 | 2016 | 1122 | 0.300 |
Why?
|
| Obesity | 1 | 2016 | 1244 | 0.290 |
Why?
|
| Postoperative Complications | 1 | 2014 | 849 | 0.290 |
Why?
|
| Adult | 7 | 2016 | 10015 | 0.260 |
Why?
|
| Female | 10 | 2016 | 21491 | 0.260 |
Why?
|
| Gestational Age | 2 | 2016 | 134 | 0.230 |
Why?
|
| Humans | 10 | 2016 | 34475 | 0.200 |
Why?
|
| Pre-Eclampsia | 2 | 2013 | 67 | 0.180 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 922 | 0.180 |
Why?
|
| Young Adult | 3 | 2016 | 2825 | 0.160 |
Why?
|
| Risk Assessment | 2 | 2014 | 1506 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 2366 | 0.140 |
Why?
|
| Time Factors | 2 | 2013 | 2352 | 0.130 |
Why?
|
| United States | 2 | 2016 | 4267 | 0.130 |
Why?
|
| Magnesium | 1 | 2015 | 30 | 0.110 |
Why?
|
| Fetal Blood | 1 | 2015 | 38 | 0.110 |
Why?
|
| Apgar Score | 1 | 2014 | 10 | 0.110 |
Why?
|
| Maternal Welfare | 1 | 2014 | 8 | 0.110 |
Why?
|
| Infusions, Intravenous | 1 | 2014 | 110 | 0.110 |
Why?
|
| Risk Factors | 2 | 2013 | 4136 | 0.110 |
Why?
|
| Birth Weight | 1 | 2014 | 51 | 0.110 |
Why?
|
| Cesarean Section, Repeat | 1 | 2014 | 10 | 0.110 |
Why?
|
| Confidence Intervals | 1 | 2014 | 155 | 0.110 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2014 | 26 | 0.110 |
Why?
|
| Case-Control Studies | 2 | 2015 | 924 | 0.110 |
Why?
|
| Prenatal Care | 1 | 2014 | 55 | 0.100 |
Why?
|
| Parity | 1 | 2013 | 21 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 306 | 0.100 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 555 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 480 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2015 | 1910 | 0.100 |
Why?
|
| Twins | 1 | 2012 | 6 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2013 | 34 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 2013 | 62 | 0.090 |
Why?
|
| Chorion | 1 | 2012 | 9 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 755 | 0.090 |
Why?
|
| Maternal Exposure | 1 | 2012 | 12 | 0.090 |
Why?
|
| Carbon Monoxide | 1 | 2012 | 10 | 0.090 |
Why?
|
| Air Pollution | 1 | 2012 | 17 | 0.090 |
Why?
|
| Air Pollutants | 1 | 2012 | 27 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 1078 | 0.090 |
Why?
|
| Risk | 1 | 2012 | 325 | 0.090 |
Why?
|
| Age Factors | 1 | 2013 | 1262 | 0.080 |
Why?
|
| Male | 3 | 2016 | 20697 | 0.080 |
Why?
|
| Incidence | 1 | 2013 | 1289 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2014 | 2461 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2014 | 3618 | 0.060 |
Why?
|
| Adolescent | 1 | 2013 | 3799 | 0.060 |
Why?
|
| Perinatal Care | 1 | 2015 | 3 | 0.030 |
Why?
|